Lisa Bitzan - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Lisa Bitzan

Showing results (1-10 of 3) with videos related to

Pageof 1

Sort By:

Molecular Cell|October 20, 2018

Rational Design of Evolutionarily Stable Microbial Kill SwitchesFinn Stirling, Lisa Bitzan, Samuel O'Keefe, et al.

Molecular Cell|November 18, 2017

Rational Design of Evolutionarily Stable Microbial Kill SwitchesFinn Stirling, Lisa Bitzan, Samuel O'Keefe, et al.

Frontiers in Neurology|January 1, 2024

Paradoxical increase of neurofilaments in SMA patients treated with onasemnogene abeparvovec-xioiMarina Flotats-Bastardas, Lisa Bitzan, Charlotte Grell, et al.

Pageof 1

Search research articles

Showing results (1-10 of 3) with videos related to

Sort By:

Pageof 1

Molecular Cell|October 20, 2018

Rational Design of Evolutionarily Stable Microbial Kill SwitchesFinn Stirling, Lisa Bitzan, Samuel O'Keefe, et al.

Molecular Cell|November 18, 2017

Rational Design of Evolutionarily Stable Microbial Kill SwitchesFinn Stirling, Lisa Bitzan, Samuel O'Keefe, et al.

Frontiers in Neurology|January 1, 2024

Paradoxical increase of neurofilaments in SMA patients treated with onasemnogene abeparvovec-xioiMarina Flotats-Bastardas, Lisa Bitzan, Charlotte Grell, et al.

Pageof 1